Inactive Instrument

Press Releases IMV Inc. Toronto S.E.

Equities

IMV Accepts an Offer from its Secured Lenders for the Sale of its Intellectual Property Assets	04/09/23	AQ
IMV Inc. : to Present at Two Upcoming Investor Conferences	13/06/19	BU
Imv : New Phase 2 Clinical Trial Results Continue to Demonstrate Potential Clinical Benefit of IMV’s DPX-Survivac in Combination with Merck’s Keytruda in Patients with DLBCL	12/06/19	BU

No results for this search